NeuroVista Receives $16,500,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24851999-996b-4bf7-adf3-b79751341719&Preview=1 -
Date
8/25/2010 -
Company Name
NeuroVista -
Mailing Address
100 Fourth Ave North Seattle, WA 98109 -
Company Description
NeuroVista Corporation is an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy. Epilepsy is a neurological condition affecting approximately 1% of the U.S. population – more than Parkinson’s disease, multiple sclerosis and Lou Gehrig’s disease combined. -
Website
http://www.neurovista.com -
Transaction Type
Venture Equity -
Transaction Amount
$16,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
GBS Venture Partners -
Venture Investor
Advanced Technology Ventures -
Venture Investor
Delphi Ventures -
Venture Investor
Foundation Medical Partners
